Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • proper noun A taxonomic genus within the family Taxaceae — coniferous shrubs and trees, including the yew.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word Taxus.

Examples

  • The newly approved Ion stent—known as Taxus Element in Europe—also uses paclitaxel.

    Boston Scientific Gets New Stent Approved Jon Kamp 2011

  • The company didn't break out sales between its own line of stents, called Taxus, and a stent from Abbott that Boston Scientific resells under a license.

    Boston Scientific's Profit Jumps 61% 2009

  • Canyons host important relict species such as Taxus baccata, Tilia platyphyllos, and Populus tremula.

    Iberian conifer forests 2007

  • Excluding some sales return reserves ahead of the domestic Ion launch, Boston Scientific estimated last week that Taxus stents had 14% U.S. market share in the first quarter, compared with 32% for Promus.

    Boston Scientific Gets New Stent Approved Jon Kamp 2011

  • It seems there are many varieties of Taxus baccata, but this may be the upright, or Fastigiata, or so it appears.

    Plum Yew-Inspiration And Adaptation « Fairegarden 2010

  • Taxus cuspidata ‘Nana Aurescens’, three of these just added to the zen garden

    Late April Mish Mash « Fairegarden 2010

  • The caption reads “Paths meander around the edge of the garden, past this cloud-pruned yew tree Taxus baccata”.

    Plum Yew-Inspiration And Adaptation « Fairegarden 2010

  • Probably a good call not swallowing that yew (Taxus) fruit - the fruit itself is not dangerous but the seed (and foliage) is extremely poisonous!

    Travelog Europe: Trees I visited DNLee 2009

  • Scientists originally isolated the drug paclitaxel — now commonly known as Taxol — in 1967 from the bark of Pacific yew trees (Taxus brevifolia) in a forest near the Mount St. Helens in Washington.

    Cancer Fighting Drug Found in Dirt | Impact Lab 2007

  • It was the same with Abbott's acquisition of Guidant's interventional cardiology business, whose Xience coated stent recently beat out Boston Scientific's Taxus in key clinical trials, and with the $3.7 billion acquisition of cholesterol drug maker Kos Pharmaceuticals in 2006.

    Hoping to Defy 2009

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.